European Archives - Page 297 of 1177 - European Medical Journal

Cardiovascular Risks Associated with Insomnia Medication

Benzodiazepine usage has been associated with increased risk of coronary heart diseases heart failure, and cardiovascular death, according to recent research.

Intravenous Iron Treatment Reduces Surgical Risks and Complications

A study has revealed that treating preoperative iron-deficiency anemia with intravenous iron significantly improves surgical outcomes compared to red blood cell transfusion.

Depressive Symptoms and Left Ventricular Diastolic Dysfunction in HIV

The prevalence of both major depressive disorder and cardiovascular disease (CVD) is higher among persons living with HIV (PWH)…

Getting Ahead of Respiratory Disease Together at ERS 2024

Ahead of the European Respiratory Society (ERS) Congress 2024 in Vienna, Austria, Alberto Papi and Cedric “Jamie” Rutland share with us…

The word spotlight on a blue background

Spotlight: August 2024

Catch up on the top pharma news stories from August in our monthly round-up. From the latest on the spread of mpox to new treatment approvals, there’s plenty to discover.

Spoonful of Technology: July-August 2024

We look at the latest examples of how pharma and its partners are working together to develop technology to solve key healthcare challenges.

Alleviation of Dyspareunia and Vaginal Dryness after Pelvic Artery Revascularisation

Vasculogenic female sexual dysfunction syndromes affect millions of ageing women worldwide, whose day-to-day symptoms of coital…

COVID-19 Vaccine Does Not Increase Multiple Sclerosis Relapse Risk

A new study involving 124,545 MS patients reveals that COVID-19 vaccination does not significantly increase relapse risk, except in those with highly active, untreated MS.

Chemotherapy-Induced Gut Microbiome Changes Linked to Cognitive Decline

A new study found a significant link between chemotherapy-induced disruptions in the gut microbiome and cognitive decline in female patients with breast cancer.

European Commission gives green light to Roche’s PNH treatment

Roche has secured European Commission approval for its drug crovalimab, marking a significant advancement in the treatment of PNH.